Shares of Extendicare Inc. (TSE:EXE - Get Free Report) hit a new 52-week high during trading on Monday following a dividend announcement from the company. The stock traded as high as C$12.90 and last traded at C$12.88, with a volume of 81017 shares trading hands. The stock had previously closed at C$12.41.
The newly announced dividend which will be paid on Monday, March 17th. Investors of record on Monday, March 17th will be given a $0.04 dividend. This represents a $0.48 annualized dividend and a yield of 3.69%. The ex-dividend date is Friday, February 28th. Extendicare's dividend payout ratio (DPR) is presently 61.20%.
Analyst Upgrades and Downgrades
EXE has been the topic of a number of recent research reports. Royal Bank of Canada increased their price objective on Extendicare from C$9.50 to C$11.00 and gave the company a "sector perform" rating in a research report on Thursday, November 28th. BMO Capital Markets raised their price target on Extendicare from C$11.00 to C$13.50 in a report on Monday. TD Securities upped their target price on shares of Extendicare from C$10.50 to C$13.00 and gave the company a "hold" rating in a research report on Monday. Finally, Cormark upgraded shares of Extendicare to a "moderate buy" rating in a research report on Wednesday, February 19th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of C$11.50.
Read Our Latest Report on EXE
Extendicare Trading Down 0.5 %
The company has a market capitalization of C$1.09 billion, a P/E ratio of 16.59 and a beta of 1.26. The business has a 50 day moving average price of C$10.84 and a 200 day moving average price of C$9.86. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.